Correlation Between Coherus BioSciences and Eiger Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coherus BioSciences and Eiger Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coherus BioSciences and Eiger Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coherus BioSciences and Eiger Biopharmaceuticals, you can compare the effects of market volatilities on Coherus BioSciences and Eiger Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coherus BioSciences with a short position of Eiger Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coherus BioSciences and Eiger Biopharmaceutica.

Diversification Opportunities for Coherus BioSciences and Eiger Biopharmaceutica

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Coherus and Eiger is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and Eiger Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eiger Biopharmaceuticals and Coherus BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coherus BioSciences are associated (or correlated) with Eiger Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eiger Biopharmaceuticals has no effect on the direction of Coherus BioSciences i.e., Coherus BioSciences and Eiger Biopharmaceutica go up and down completely randomly.

Pair Corralation between Coherus BioSciences and Eiger Biopharmaceutica

If you would invest  72.00  in Coherus BioSciences on August 29, 2024 and sell it today you would earn a total of  56.00  from holding Coherus BioSciences or generate 77.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.35%
ValuesDaily Returns

Coherus BioSciences  vs.  Eiger Biopharmaceuticals

 Performance 
       Timeline  
Coherus BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Coherus BioSciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Eiger Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eiger Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Eiger Biopharmaceutica is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Coherus BioSciences and Eiger Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coherus BioSciences and Eiger Biopharmaceutica

The main advantage of trading using opposite Coherus BioSciences and Eiger Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coherus BioSciences position performs unexpectedly, Eiger Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eiger Biopharmaceutica will offset losses from the drop in Eiger Biopharmaceutica's long position.
The idea behind Coherus BioSciences and Eiger Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements